SCHEMBL7082294

SCHEMBL7082294

Cc1ccsc1/C(=N\O)c1ccc(Nc2ccccc2[N+](=O)[O-])cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 9/20 0.63
MAPK13 O15264 8/20 0.63
MAPK12 P53778 8/20 0.63
MAPK11 Q15759 8/20 0.63
KMT2A Q03164 5/20 0.43
MAPT P10636 5/20 0.43
MEN1 O00255 4/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 3/20 0.42
MAPK1 P28482 2/20 0.42
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
LMNA P02545 3/20 0.41
EPAS1 Q99814 1/20 0.40
ALDH1A1 P00352 5/20 0.40
CASP7 P55210 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082296 1.00 MAPK14 (0.63) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7080484 0.91 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7080486 0.91 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7079569 0.87 MAPK13 (0.72) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7076502 0.86 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7074453 0.86 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7074450 0.86 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7077166 0.83 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7077163 0.83 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7077192 0.80 MAPK13 (0.67) MAPK14MAPK13MAPK12MAPK11KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.